Abstract
The interface between laboratory investigation and clinical oncology remains an area of productive discussion between cell biologists and physicians treating malignancies. Researchers in cell biology have developed techniques for cloning human tumor cells, which now permit in vitro studies of fresh human tumors as well as established cell lines. These technical advances have become standardized among laboratories, and a human tumor clonogenic assay (HTCA) now is done on primary human tumors in many centers throughout the world [1–3]. Some types of human tumors have been easier to grow in vitro than others. Specifically, cancers of the ovary [4], lung [5, 6], breast [7, 8], and melanomas [9, 10] have been successfully grown in many laboratories, studying the effects of colony formation following treatment with various cytotoxic drugs.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Salmon SE. 1984. Human tumor colony assay and chemosensitivity testing. Cancer Treat Rep 68:117–125.
Kern DH, Bertelsen CA, Mann BD, Campbell MA, Morton DL, Cochran AJ. 1983. Clinical application of the clonogenic assay. Ann Clin Lab Sci 13:10–15.
Hug V, Thames H, Johnston D, Blumenschein G, Drewinko B, Spitzer G. 1984. The true predictive value of the human tumor stem cell assay: does a workable assay select for treatment responders? J Clin Oncol 2:42–45.
Welander CE, Homesley HD, Jobson VW. 1983. In vitro chemotherapy testing of gynecologic tumors: basis for planning therapy? Am J Obstet Gynecol 147:188–195.
Kitten CM, Von Hoff DD, Bennett EV Jr, Grover FL. 1982. Growth of lung cancer in a human tumor clonogenic system. J Thorac Cardiovasc Surg 83:363–371.
Bertelsen CA, Kern DH, Kaiser LR, Mann BD, Holmes EC, Morton DL. 1983. Biopsy of thoracic neoplasms for assay of chemosensitivity. Arch Surg 118:1074–1076.
Sutherland CM, Mather FJ, Carter RD, Cerise EJ, Krementz ET. 1983. Breast cancer as analyzed by the human tumor stem cell assay. Surgery 94:370–375.
Sandbach J, Von Hoff DD, Clark G, Cruz AB, O’Brien M. 1982. Direct cloning of human breast cancer in soft agar. Cancer 50:1315–1321.
Meyskens FL, Soehnlen BJ, Saxe DF, Casey WJ, Salmon SE. 1981. In vitro clonal assay for human metastatic melanoma, cells. Stem Cells 1:61–72.
Tveit KM, Fodstad O, Lotsberg J, Vaage S, Phil A. 1982. Colony growth and chemosensitivity in vitro of human melanoma biopsies. Relationship to clinical parameters. Int J Cancer 29:533–538.
Parker RL, Welander CE, Homesley HD, Jobson VW, Kawamoto EH. 1984. Use of the human tumor stem cell assay to study chemotherapy sensitivity of cancer of the cervix. Obstet Gynecol 64:412–416.
Carrel A, Burrows MT. 1911. Cultivation of tissues in vitro and its technique. J Exp Med 13:387–396.
Carrel A, Burrows MT 1911. Cultivation in vitro of malignant tumors. J Exp Med 13:571–575.
Gey G. 1952. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res 12:264.
Fogh J, Trempe G. 1975. New human cell lines. In: Human tumors cells cells in vitro (J Fogh, ed). Plenum Press, New York, pp 115–159.
Wright JC, Walker D. 1975. A predictive test for the selection of cancer chemotherapeutic agents for the treatment of human cancer. J Surg Oncol 7:381–392.
Berry RJ, Laing AH, Wells J. 1975. Fresh explant culture of human tumors in vitro and the assessment of sensitivity to cytotoxic chemotherapy. Br J Cancer 31:218–227.
Roper PR, Drewinko B. 1976. Comparison of in vitro methods to determine drug-induced cell lethality. Cancer Res 36:2181–2188.
Shrivastav S, Bonar RA, Stone KR, Paulson DF. 1980. An in vitro assay procedure to test chemotherapeutic drugs on cells from human solid tumors. Cancer Res 40:4438–4442.
Volm M. 1981. In vitro short-term test to determine the resistance of human tumors to chemotherapy. Cancer 48:2127–2135.
Hamburger AW, Salmon SE. 1977. Primary bioassay of human tumor stem cells. Science 197:461–463.
Leibovitz A, Liu R, Hayes C, Salmon SE. 1983. A hypo-osmotic medium to disaggregate tumor cell clumps into viable and clonogenic single cells for the human tumor stem cell clonogenic assay. Int J Cell Cloning 1:478–485.
Welander CE, Natale RB, Lewis JR Jr. 1982. In vitro growth stimulation of human ovarian cancer cells by xenogeneic peritoneal macrophages. J Natl Cancer Inst 69:1039–1047.
Bonomi P, Blessing JA, stehman FB, DiSaia PJ, Walton L, Major FJ. 1985. Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix. A Gynecologic Oncology Group Study. J Clin Oncol 13:1079–1085.
Blum RH, Carter SK, Agre K. 1973. A clinical review of bleomycin. A new antineoplastic agent. Cancer 31:903–914.
Trope C, Johnsson JE, Simonsen E, Sigurdsson K, Stendahl U, Mattsson W, Gullberg B. 1983. Bleomycin-mitomycin C in advanced carcinoma of the cervix. A third look. Cancer 51:591–593.
Alberts DS, Martimbeau PW, Surwit EA, oishi N. 1981. Mitomycin-C, bleomycin, vincristine, and cisplatinum in the treatment of advanced recurrent squamous cell carcinoma of the cervix. Cancer Clin Trials 4:313–316.
Alberts DS, Chen HSC. 1980. Tabular summary of pharmacokinetic parameters relevant to in vitro drug assay. In: Cloning of human tumor stem cells (SE Salmon, ed.). Alan R. Liss, Inc., New York, pp 351–359.
Alberts DS, Salmon SE, Chen HSG, Moon TE, Young L, Surwit EA. 1981. Pharmacologic studies of anticancer drugs with the human tumor stem cell assay. Cancer Chemother Pharmacol 6:253–264.
Sondak VK, Korn EI, Morton DL, Kern DH. 1983. Absence of in vitro synergy for chemotherapeutic combinations tested in the clonogenic assay. Proc Am Assoc Cancer Res 24:316.
Welander CE, Morgan TM, Homesley HD, Trotta PP, Spiegel RJ. 1985. Combined recombinant human interferon alpha2 and cytotoxic agents studied in the clonogenic assay. Int J Cancer 35:721–729.
Sykes JA, Whitescarver J, Jernstrom P, Nolan JF. 1970. Some properties of a new epithelial cell line of human origin. J Natl Cancer Inst 45:107–122.
Pattillo RA, Hussa RO, Story MT, Ruckert ACF, Shalaby MR, Mattingly RF. 1977. Tumor antigen and human chorionic gonadotropin in CaSki cells: a new epidermoid cervical cancer cell line. Science 196:1456–1458.
Welander CE, Muss HB, Morgan TM, Trotta PP, Spiegel RJ. 1985. Synergy in vitro and in clinical trials. Inb: Interferon alpha-2: preclinical and clinical evaluation (DL Kisner, JF Smyth, eds). Martinus Nijhoff, Boston, pp 29:39.
Von Hoff DD, Clark GM, Stogdill BJ, Sarosdy MF, O’Brien MT, Casper JT, Mattox DE, Page CP, Cruz AB, Sandbach JF. 1983. Prospective clinical trial of a human tumor cloning system. Cancer Res 43:1926–1931.
Coldman AJ, Goldie JH. 1982. A mathematical model of drug resistance in neoplasms. In: Drug and hormone resistance in neoplasia, Volume 1 (N Bruchovsky, JH Goldie, eds). CRC Press, Inc., pp 55–78.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publisher, Boston
About this chapter
Cite this chapter
Welander, C.E., Parker, R.L. (1987). Human tumor clonogenic assay studies of cervical cancer. In: Surwit, E.A., Alberts, D.S. (eds) Cervix Cancer. Cancer Treatment and Research, vol 31. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2027-2_12
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2027-2_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9207-4
Online ISBN: 978-1-4613-2027-2
eBook Packages: Springer Book Archive